A Bioavailability Study of NALDEBAIN ER Injection and Nalbuphine Injection in Healthy Volunteers.
Clinical trial NCT04256434 · COMPLETED
Trial details
- NCT number
- NCT04256434
- Sponsor
- Lumosa Therapeutics Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-31
- Primary completion
- 2020-05-29
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.